MANF (Mesencephalic Astrocyte-Derived Neurotrophic Factor)
Introduction
Mermaid diagram (expand to render)
The MANF gene (Mesencephalic Astrocyte-Derived Neurotrophic Factor), also known as ARMET (Arginine-rich, Mutated in Early stage Tumors), encodes a unique neurotrophic factor with distinctive mechanisms of action distinct from classical neurotrophic factors like BDNF or GDNF. Discovered in 2003, MANF has emerged as a promising therapeutic target for multiple neurodegenerative conditions, particularly [Parkinson's disease](/diseases/parkinsons-disease), [Alzheimer's disease](/diseases/alzheimers-disease), [stroke](/diseases/stroke), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)[@lindholm2020][@cheng2023].
Unlike traditional neurotrophic factors that signal through specific receptor tyrosine kinases, MANF exerts its neuroprotective effects primarily through modulation of [endoplasmic reticulum](/entities/endoplasmic-reticulum) (ER) stress responses and direct chaperone activity. This unique mechanism positions MANF as a particularly attractive therapeutic agent for diseases characterized by protein misfolding and ER dysfunction["@yang2024"][@aparekh2021].
<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>MANF</td></tr>
<tr><th>Full Name</th><td>Mesencephalic Astrocyte-Derived Neurotrophic Factor</td></tr>
<tr><th>Chromosomal Location</th><td>3p21.2</td></tr>
<tr><th>NCBI Gene ID</th><td>54584</td></tr>
<tr><th>OMIM</th><td>609842</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000131791</td></tr>
<tr><th>UniProt ID</th><td>Q99986</td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Alzheimer's Disease, Stroke, ALS, Glioblastoma</td></tr>
<tr><th>Protein Length</th><td>182 amino acids</td></tr>
<tr><th>Protein Family</th><td>ARMET family</td></tr>
</table>
</div>
Gene Structure and Organization
The MANF gene spans approximately 5.2 kb and consists of 4 exons encoding a 182-amino acid protein. The gene structure reveals several important features:
- Exon 1: Encodes the signal peptide and N-terminal portion
- Exon 2-4: Encode the C-terminal secreted domain with cysteine-rich regions
The promoter region contains multiple regulatory elements including:
- ATF4 response elements (amino acid response)
- ER stress response elements (UPRE)
- Antioxidant response elements (ARE)
Expression is induced by various cellular stresses including:
- Amino acid deprivation
- ER stress
- Oxidative stress
- Ischemia
- Neuroinflammation[@petrova2022]
Protein Structure and Function
Domain Architecture
MANF possesses a distinctive bipartite structure critical for its function:
N-terminal ER Retention Domain (1-60 aa):
- Contains RTDL sequence for ER localization
- Arginine-rich region for protein-protein interactions
- Direct binding to misfolded proteins
- Interaction with BiP/GRP78 chaperone
C-terminal Secreted Domain (61-182 aa):
- Four conserved cysteine residues forming disulfide bonds
- Novel protein fold distinct from other neurotrophic factors
- Neurotrophic activity region
- Receptor binding domain
Molecular Mechanisms
MANF operates through multiple molecular pathways[@zhou2022][@konovalova2020]:
1. ER Stress Modulation:
- Direct chaperone activity on misfolded proteins
- Stabilization of ER membrane integrity
- Interaction with BiP/GRP78 to regulate UPR
- Modulation of PERK, IRE1, and ATF6 pathways
2. PI3K/Akt Signaling:
- Activation promotes cell survival
- Phosphorylation of BAD
- mTORC1 activation
- Critical for dopaminergic neuron survival
3. MAPK/ERK Pathway:
- Stimulation of neuronal differentiation
- Plasticity mechanisms
- Anti-apoptotic effects
4. NF-κB Inhibition:
- Suppression of neuroinflammation
- Reduced cytokine production
- Protection in PD and AD models[@yang2024]
Normal Function in the Nervous System
Expression Patterns
MANF shows widespread and region-specific expression in the nervous system[@petrova2022][@shen2018]:
| Brain Region | Expression Level | Primary Cell Type |
|--------------|------------------|-------------------|
| Substantia nigra | High | Dopaminergic neurons |
| Hippocampus (CA1-CA3) | High | Pyramidal neurons |
| Cortex | Moderate-High | Pyramidal neurons, interneurons |
| Cerebellum | Moderate | Purkinje cells, granule cells |
| Spinal cord | Moderate | Motor neurons |
| Striatum | Moderate | Medium spiny neurons |
Cellular Sources:
- Neurons: Constitutive expression, upregulated by stress
- Astrocytes: Major source of secreted MANF
- Microglia: Inducible expression during inflammation
Physiological Roles
Neuroprotection:
- Protects against 6-OHDA, MPTP, rotenone toxicity
- Protects against [amyloid-beta](/proteins/amyloid-beta) oligomers
- Preserves mitochondrial membrane potential
- Maintains ATP production
Synaptic Function:
- Modulates synaptic vesicle release
- Regulates dendritic spine morphology
- Promotes synaptic plasticity
ER Homeostasis:
- Chaperone-like activity
- UPR modulation
- Calcium homeostasis
Role in Neurodegenerative Diseases
Parkinson's Disease
MANF is highly relevant to [Parkinson's disease](/diseases/parkinsons-disease) pathogenesis[@lindholm2020][@voutilainen2015][@shen2018]:
Expression Alterations:
- MANF mRNA reduced in PD substantia nigra
- Protein levels decreased in striatum
- Correlate with disease severity
Protective Mechanisms:
- AAV-MANF delivery protects dopaminergic neurons
- 6-OHDA lesion model shows neuroprotection
- MPTP model demonstrates attenuation of degeneration
- Reduces neuroinflammation
Genetic Associations:
- Promoter variants associated with PD risk
- SNP rs12765680 correlates with earlier onset[@dan2018]
Therapeutic Potential:
- AAV-MANF gene therapy in clinical development
- Recombinant protein delivery
- Small molecule MANF inducers
Alzheimer's Disease
MANF dysfunction contributes to [Alzheimer's disease](/diseases/alzheimers-disease) through several mechanisms[@gonzalez2017]:
Pathological Involvement:
- MANF levels reduced in AD hippocampus
- Protects against Aβ oligomer toxicity
- May enhance Aβ clearance via [autophagy](/entities/autophagy)
- Reduces ER stress in neurons with pathology
Therapeutic Implications:
- MANF overexpression improves cognition in AD models
- Reduces amyloid plaque burden
- Protects synaptic function
Stroke and Ischemia
MANF is strongly upregulated following [cerebral ischemia](/diseases/stroke)[@airavaara2021]:
Response to Injury:
- Expression increases 4-8 hours post-infarct
- Peaks at 24-48 hours
- Continues for several days
Protective Effects:
- Reduces infarct size
- Improves functional recovery
- Promotes angiogenesis
- Protects blood-brain barrier
Mechanisms:
- ER stress protection
- Anti-apoptotic signaling
- Anti-inflammatory effects
Amyotrophic Lateral Sclerosis
In [ALS](/diseases/amyotrophic-lateral-sclerosis), MANF shows altered expression in motor neurons and astrocytes[@hu2019]:
Expression Changes:
- Elevated in ALS motor neurons
- Astrocytic MANF increased
- May reflect attempted neuroprotection
Therapeutic Potential:
- Protects motor neurons from excitotoxicity
- Modulates astrocyte-mediated inflammation
- Gene therapy approaches under investigation
Glioblastoma
Recent research reveals MANF involvement in [glioblastoma](/diseases/glioblastoma)[@entchev2020]:
- Anti-tumor effects
- Induction of apoptosis in glioma cells
- Potential therapeutic targeting
Therapeutic Implications
Gene Therapy
AAV-mediated MANF delivery represents a promising approach[@matsuoka2019]:
Delivery Methods:
- AAV serotype 2/9 for CNS targeting
- Intraparenchymal injection
- Systemic delivery with BBB-penetrant vectors
Preclinical Results:
- Sustained MANF expression
- Protected dopaminergic neurons
- Improved motor function
- No adverse effects observed
Protein Therapy
Recombinant MANF protein delivery[@liu2021]:
- Modified for BBB penetration
- Extended half-life formulations
- Direct injection or nanoparticle delivery
- Demonstrated neuroprotection in models
Small Molecule Inducers
Pharmacological upregulation of endogenous MANF:
- Valproic acid increases MANF expression
- TUDCA (tauroursodeoxycholic acid) elevates MANF
- GSK3β inhibitors enhance expression
Biomarker Potential
MANF as a biomarker for neurodegeneration[@park2021]:
- Detectable in cerebrospinal fluid
- Reduced in PD and AD patients
- Potential for disease progression monitoring
Animal Models
| Model | Key Findings | Reference |
|-------|-------------|------------|
| MANF knockout mice | Progressive dopaminergic neuron loss | Cheng 2023 |
| 6-OHDA lesion + MANF | Overexpression protects against lesion | Voutilainen 2015 |
| MPTP model + MANF | Attenuates MPTP-induced degeneration | Lindholm 2020 |
| Transgenic MANF mice | Improved motor performance | Matsuoka 2019 |
| Ischemia model + MANF | Reduced infarct size | Airavaara 2021 |
Research Directions
Current research priorities include:
Receptor Identification: Complete characterization of MANF receptor(s) and downstream signaling
Delivery Optimization: Developing efficient CNS delivery methods for MANF protein
Clinical Translation: Moving MANF therapies toward human clinical trials
Biomarker Development: MANF as a biomarker for diagnosis and progression
Combination Therapies: MANF with other neurotrophic factors or disease-modifying drugs
Genetic Variants: Understanding how MANF variants affect disease risk and progression[@mizobata2020]Cross-References
- [MANF Protein](/proteins/manf-protein) — Protein detailed page
- [Parkinson's Disease](/diseases/parkinsons-disease) — Associated disorder
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Associated disorder
- [Neurotrophic Factors](/mechanisms/neurotrophic-factors) — Pathway overview
- [Dopaminergic Neurons](/cell-types/dopaminergic-neurons) — Target cell type
- [ER Stress Pathway](/mechanisms/er-stress-pathway) — Key mechanism
- [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction-pathway) — Related pathway
- [Stroke](/diseases/stroke) — Associated disorder
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — Associated disorder
External Resources
- [NCBI Gene: MANF](https://www.ncbi.nlm.nih.gov/gene/54584)
- [UniProt: MANF (Q99986)](https://www.uniprot.org/uniprot/Q99986)
- [Human Protein Atlas: MANF](https://www.proteinatlas.org/ENSG00000131791-MANF)
- [Ensembl: MANF](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000131791)
- [GeneCards: MANF](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MANF)
Pathway Diagram
The following diagram shows the key molecular relationships involving MANF Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)